India Animal Pharmaceuticals Market to Grow with a CAGR of 7.50% through 2030

Growing availability of veterinary hospitals and clinics and growing occurrences of zoonotic diseases is expected to drive the India Animal Pharmaceuticals Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “India Animal Pharmaceuticals Market - By Region, Competition Forecast & Opportunities, 2030F”, India Animal Pharmaceuticals Market was valued at USD 1.28 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.50% through 2030. The India Animal Pharmaceuticals Market is experiencing significant growth, driven by a range of factors. The increasing livestock population and the rising incidence of animal diseases are augmenting the demand for animal pharmaceuticals.

The growing pet adoption trend, coupled with rising awareness about pet health among urban population, is also contributing to the market expansion. Other drivers include technological advancements in animal healthcare, government initiatives towards animal health, and the increasing export of meat and dairy products.

The Indian Animal Pharmaceuticals Market is a fast-evolving and dynamic sector that holds a crucial and irreplaceable role in the development, supply, and accessibility of medicines tailored specifically for animal health. With continuous expansion and innovation, this flourishing market covers a broad spectrum of pharmaceutical products that serve not only pets and livestock but also a diverse range of animals, ensuring their overall wellness and optimal health outcomes. The market offers a comprehensive array of essential medications, such as vaccines, antibiotics, antiparasitics, feed additives, and other therapeutic drugs, all designed to address the unique health requirements of various animal species. These pharmaceutical interventions play a vital role in promoting animal welfare and protecting their health, thereby contributing significantly to food safety and national food security.

Recent trends, including a sharp rise in pet ownership and increased focus on livestock wellness, have propelled the Indian animal pharmaceuticals market forward. The heightened awareness of zoonotic diseases—those transmissible between animals and humans—has underscored the necessity of investing in robust animal healthcare and disease prevention strategies. Through the delivery of innovative and effective pharmaceutical products, the Indian Animal Pharmaceuticals Market has become a vital and irreplaceable pillar within the broader animal healthcare ecosystem. Its critical contributions help advance animal life expectancy and well-being, while simultaneously safeguarding the stability and sustainability of the food supply chain. By consistently pursuing excellence and embracing technological advancements, this market is well-positioned to elevate animal healthcare standards, shaping a healthier future for both animals and people. This vibrant and ever-expanding market offers abundant opportunities for both Indian and global players. Driven by a growing animal husbandry industry, demand for veterinary medicines and health products is accelerating. With India possessing the world’s largest livestock population, the nation provides an especially attractive environment for companies in the animal pharmaceuticals space.    

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Animal Pharmaceuticals Market.”

The India Animal Pharmaceuticals Market is segmented into product type, product, animal type, registration, regional distribution, and company.

Based on registration, in the Indian animal pharmaceuticals market, patented drugs currently hold dominance over generic ones. This trend is primarily driven by the robust research and development efforts undertaken by pharmaceutical companies, where they invest substantial resources in developing innovative drugs and securing patent rights to protect their investments and capitalize on their innovations. However, the market dynamic is gradually shifting towards generic drugs. This shift can be attributed to several factors, including the expiration of several key patents, which paves the way for generic alternatives to enter the market. The increasing demand for affordable and effective animal pharmaceuticals has contributed to the rising popularity of generic drugs. Their affordability makes them more accessible to a wider range of consumers, which further fuels their demand and adoption in the market. As the demand for affordable and effective animal pharmaceuticals continues to grow, the market landscape is expected to evolve further. While patented drugs still hold a dominant position, the rise of generic drugs represents a significant shift in the industry. This changing dynamic presents both challenges and opportunities for pharmaceutical companies as they navigate the delicate balance between innovation, patent protection, and market demand.

Based on region, the fastest-growing zone in the Indian Animal Pharmaceuticals Market is South India, driven by a strong presence of poultry and dairy farming, increasing pet ownership, and well-established veterinary infrastructure. States like Andhra Pradesh, Tamil Nadu, Karnataka, and Telangana are witnessing rapid growth due to their large livestock populations, high consumption of animal-based products, and government support for animal health initiatives. Andhra Pradesh and Tamil Nadu are leading poultry hubs, contributing significantly to the demand for antibiotics, vaccines, and feed additives. The urban centers like Bengaluru and Hyderabad have seen a rise in companion animal care, fueling growth in pet pharmaceuticals. The presence of several veterinary research institutes and pharmaceutical manufacturing units in this region further boosts innovation and supply chain efficiency. With increasing awareness, better access to veterinary care, and ongoing investments in livestock productivity, South India is emerging as a critical and dynamic growth engine for the country’s animal health sector.

Major companies operating in India Animal Pharmaceuticals Market are:

·         SeQuent Scientific Limited

·         Elanco India Private Limited

·         Merck Animal Health

·         Phibro Animal Health Limited

·         Boehringer Ingelheim Animal Health

·         Zoetis India Limited

·         Virbac Animal Health India Private Limited

·         Vetoquinol India Animal Health Private Limited

·         Perrigo Laboratories India Private Limited

·         Bayer (India) Limited

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The animal pharmaceuticals market in India is poised for strong growth, driven by several key factors. Rising cases of animal diseases and a growing livestock population, fueled by demand for animal-based products, are major contributors. Increased awareness of animal health and supportive government initiatives are further accelerating market momentum. Advancements in veterinary healthcare, including new vaccines and medications, are enhancing treatment options. These trends collectively signal a promising future for India’s animal pharmaceutical sector” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“India Animal Pharmaceuticals Market By Product Type (Vaccine, Parasiticides, Anti-Infectives, Others), By Product [Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others) Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others) Anti-Inflammatories (NSAIDs, Corticosteroids, Others) Bronchodilators (Theophylline, Albuterol, Others)], By Animal Type (Companion Animals, Livestock), By Registration (Generic, Patented), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Animal Pharmaceuticals Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Animal Pharmaceuticals Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com